Private Equity, VC & Investor
Breega vs Hoxton Ventures
Structured technology and market comparison · 2026
Direct Feature Comparison
Breega · vs · Hoxton VenturesEuropean and African early-stage venture capital fund manager.
European pre-seed and seed venture capital investor.
Analyze all overlapping signals and tech stacks for Breega and Hoxton Ventures
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Breega and Hoxton Ventures?
When comparing Breega and Hoxton Ventures, both platforms operate within the Private Equity, VC & Investor ecosystem. Breega is positioned as European and African early-stage venture capital fund manager, whereas Hoxton Ventures focuses on European pre-seed and seed venture capital investor. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Breega and Hoxton Ventures?
When evaluating Breega and Hoxton Ventures, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Breega and Hoxton Ventures compare?
Breega is headquartered in FR (founded in 2013) with 10–49 employees. Hoxton Ventures is based in GB (founded in 2013) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Breega vs Hoxton Ventures
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Breega
Recent Signals
- ·EU-Startups (European Venture)Funding
Cori Clinical Raises €3.8M to Accelerate Clinical Trials
London-based Cori Clinical, a startup providing an AI-powered intelligence layer for clinical trials, has raised €3.8 million in a Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures, and Bynd. The company plans to use the funds to expand delivery capacity, grow its team, and deepen regulatory and clinical intelligence in its platform. Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health. Founded in 2025 by Jorn Jansen Schoonhoven (CEO) and Patricio Fernández (CTO), Cori Clinical creates a 'living blueprint' for trials, integrating internal knowledge with external data from registries and regulatory bodies like FDA, MHRA, and EMA. The startup claims its approach could reduce average trial set-up costs by at least 33%. It already works with two of the top five global CROs and has customers like Erasmus MC.
- Cori Clinical raised €3.8 million in a Seed round led by Breega.
- Participants include Enzo, Heartfelt, Together Ventures, and Bynd.
- Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health.
Hoxton Ventures
Recent Signals
- ·Tech.eu (European Tech & Deals)Biotech
Hoxton Ventures Backs Human Hair Toothpaste Pioneer in $4M Seed Round
Hoxton Ventures is co-leading a $4 million seed round in Eterna Regeneratives, a UK-based biotech startup focused on dental and bone repair. The company, founded in 2024 as a spinout from King's College London, is developing a platform that utilizes keratin, a protein derived from human hair or sheep's wool, to create a toothpaste or gel that repairs damaged tooth enamel. Eterna claims that keratin, when combined with saliva minerals, generates a protective coating on teeth that mimics natural enamel and could be more effective than fluoride in preventing tooth decay. The Venture Collective is the other co-lead in the round. The company aims to address tooth decay, which affects nearly 90% of adults and 46% of children. Hussein Kanji, co-founder of Hoxton Ventures, expressed enthusiasm about the breakthrough. The funding will help commercialize the technology, which currently targets enamel and bone repair.
- Hoxton Ventures is co-leading a $4 million seed round in Eterna Regeneratives.
- The Venture Collective is co-leading the round with Hoxton Ventures.
- Eterna Regeneratives is a UK-based startup founded in 2024 and spun out from King's College London.
- ·Tech.eu (European Tech & Deals)Funding
Veridion raises $20M for live business intelligence platform
Bucharest-based business intelligence startup Veridion (formerly Soleadify) has raised $20 million (€17.5 million) in Series A funding led by Hoxton Ventures, with participation from Underline Ventures, OTB Ventures, Gapminder, Day One Capital, and Launchub. The company provides a continuously updated 'live business graph' covering around 640 million businesses worldwide, analyzing billions of digital signals from public sources. The funding will support international expansion, product development, and team growth. Veridion serves over 100 organizations and employs more than 60 people across Europe and North America. The platform aims to replace static, quarterly-updated business intelligence with real-time, decision-grade data for enterprise-scale systems, helping organizations understand commercial risk, market shifts, and supply chain disruptions.
- Veridion raised $20 million (€17.5 million) in Series A funding led by Hoxton Ventures.
- The round included participation from Underline Ventures, OTB Ventures, Gapminder, Day One Capital, and Launchub.
- Veridion's platform covers around 640 million businesses worldwide (up to 642 million).
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Breega and Hoxton Ventures share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks